“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

Jeremy Grummet, Michael A. Gorin, Rick Popert, Tim O’Brien, Alastair D. Lamb, Boris Hadaschik, Jan Philipp Radtke, Florian Wagenlehner, Eduard Baco, Caroline M. Moore, Mark Emberton, Arvin K. George, John W. Davis, Richard J. Szabo, Roger Buckley, Andrew Loblaw, Matthew Allaway, Christof Kastner, Erik Briers, Peter L. RoyceMark Frydenberg, Declan G. Murphy, Henry H. Woo

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalProstate Cancer and Prostatic Diseases
DOIs
StateAccepted/In press - Jan 1 2020

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research

Cite this

Grummet, J., Gorin, M. A., Popert, R., O’Brien, T., Lamb, A. D., Hadaschik, B., Radtke, J. P., Wagenlehner, F., Baco, E., Moore, C. M., Emberton, M., George, A. K., Davis, J. W., Szabo, R. J., Buckley, R., Loblaw, A., Allaway, M., Kastner, C., Briers, E., ... Woo, H. H. (Accepted/In press). “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-0204-8